This document discusses the reversal of various antithrombotic agents, including antiplatelet drugs, anticoagulants, and thrombolytics. It provides information on the mechanisms of action, dosing, monitoring, and reversal strategies for aspirin, clopidogrel, unfractionated heparin, low molecular weight heparin, fondaparinux, warfarin, dabigatran, rivaroxaban, and thrombolytics. For elective procedures, most agents should be stopped 24-72 hours beforehand. For emergencies, the document outlines specific reversal agents like protamine, idarucizumab, factor concentrates, and transfusions when needed to rapidly reverse the